The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Cardiovascular Hospitalizations and Mortality Among Recipients of Hematopoietic Stem Cell Transplantation
Abstract
BACKGROUND: Hematopoietic stem cell transplantation (HSCT) is increasingly used to treat multiple malignant and nonmalignant conditions. The risk for cardiovascular disease after the procedure has not been well-described. OBJECTIVE: To compare rates and hazards of cardiovascular-related hospitalization and death among persons who were still alive at least 2 years after HSCT with those in a population-based sample. DESIGN: Retrospective cohort study. SETTING: Comprehensive cancer center. PATIENTS: 1491 patients who had survived 2 years or longer after HSCT received between 1985 and 2006, and frequency-matched persons who were randomly selected from drivers' license files in the state of Washington. MEASUREMENTS: Cardiovascular hospitalizations and death, as determined from statewide hospital discharge records and death registries in Washington. RESULTS: Compared with the general population, transplant recipients experienced increased cardiovascular death (adjusted incidence rate difference, 3.6 per 1000 person-years [95% CI, 1.7 to 5.5]). Recipients also had an increased cumulative incidence of ischemic heart disease, cardiomyopathy or heart failure, stroke, vascular diseases, and rhythm disorders and an increased incidence of related conditions that predispose toward more serious cardiovascular disease (hypertension, renal disease, dyslipidemia, and diabetes). No consistent differences in hazards were observed after total-body irradiation or receipt of an allogeneic versus an autologous graft, aside from an increased rate of hypertension among recipients of allogeneic grafts. Disease relapse after transplantation was associated with an increased hazard of cardiovascular death (hazard ratio, 2.3 [CI, 1.1 to 4.8]). LIMITATION: All patients received HSCT at a single institution, and no information was available on pretransplantation treatment and lifestyle factors that may influence risk for cardiovascular disease. CONCLUSION: Increased rates of cardiovascular disease should be taken into account when caring for patients who have received HSCT. Future efforts should be directed toward improved screening and controlling of factors that predispose toward cardiovascular disease. PRIMARY FUNDING SOURCE: The American Society for Blood and Marrow Transplantation, the Leukemia and Lymphoma Society, and the Seattle Children's Research Institute.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
State of disparities in cardiovascular health in the United States.
Mensah, G. A., Mokdad, A. H., Ford, E. S., Greenlund, K. J., & Croft, J. B. (2005) · Circulation · doi:10.1161/01.cir.0000158136.76824.04 · Cited by 1,213 · cited 1×
“Given that rates of cardiovascular disease vary by race or ethnicity in both directions (40), the direction of any bias due to differences in race or ethnicity is difficult to predict.”
BackgroundChronic kidney disease in long-term survivors of hematopoietic cell transplant
Hingorani, S., Guthrie, K. A., Schoch, G., Weiss, N. S., & McDonald, G. B. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705573 · Cited by 149 · cited 1×
“Finally, HSCT has been associated with increased chronic renal disease (28), which is an independent risk factor for cardiovascular disease in the general population (29).”
BackgroundIves, D. G., Samuel, P., Psaty, B. M., & Kuller, L. H. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.02056.x · Cited by 108
Cited by
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862
Armenian, S. H., Lacchetti, C., Barac, A., Carver, J., Constine, L. S., Denduluri, N., Dent, S., Douglas, P. S., Durand, J.-B., Ewer, M., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.5400 · Cited by 1,290
Armenian, S. H., Hudson, M. M., Mulder, R. L., Chen, M. H., Constine, L. S., Dwyer, M., Nathan, P. C., Tissing, W. J. E., Shankar, S., Sieswerda, E., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70409-7 · Cited by 570
Gilchrist, S. C., Barac, A., Ades, P. A., Alfano, C. M., Franklin, B. A., Jones, L. W., La Gerche, A., Ligibel, J. A., Lopez, G., Madan, K., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000679 · Cited by 472
Metadata
- Authors
- Chow, E. J., Mueller, B. A., Baker, K. S., Cushing-Haugen, K. L., Flowers, M. E. D., Martin, P. J., Friedman, D. L., & Lee, S. J.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2011-07-05
- Volume
- 155
- Issue
- 1
- Pages
- 21-32
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2058518472
- Cited by
- 215
- References
- 3
- FWCI
- 5.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cardiovascular Hospitalizations and Mortality Among Recipients of Hematopoietic Stem Cell Transplantation. https://app.cochat.ai/papers/10.7326/0003-4819-155-1-201107050-00004
- The paper
- Chow, E. J., Mueller, B. A., Baker, K. S., Cushing-Haugen, K. L., Flowers, M. E. D., Martin, P. J., Friedman, D. L., & Lee, S. J. (2011). Cardiovascular Hospitalizations and Mortality Among Recipients of Hematopoietic Stem Cell Transplantation. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-155-1-201107050-00004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.